Area 23, 2e Creative, and Digitas Health win big at 2017 MM&M Awards

Area 23, 2e Creative, and Digitas Health win big at 2017 MM&M Awards

Area 23 netted three gold awards, and 2e Creative won Small Agency of the Year for the third year in a row.

Up to 20% of pharma brands moving digital media spend to point-of-care

Up to 20% of pharma brands moving digital media spend to point-of-care

Two point-of-care companies have received hundreds of millions of dollars in funding. One of them, Outcome Health, is facing allegations about padding data.



Linda Ruschau, chief client officer of PatientPoint, talks with Larry Dobrow, senior editor at MM&M, about how to better engage with HCPs. The questions and topic were created and selected by the MM&M editorial staff. The video is sponsored by PatientPoint.


My career in 5 executions: Saatchi & Saatchi Wellness' Kathy Delaney

My career in 5 executions: Saatchi & Saatchi Wellness' Kathy Delaney

From IKEA to eye-opening health campaigns, S&S Wellness' CCO helps turn emotion into action.

Phoenix House tries to change the perception of rehab

Phoenix House tries to change the perception of rehab

The organization rolled out a video this week as part of its Live Unaddicted campaign to change the perception of addiction treatment.

Five things for pharma marketers to know: Friday, October 20, 2017

Five things for pharma marketers to know: Friday, October 20, 2017

Merck lays off 1,800 employees, launches new sales force; Celgene ends development of Crohn's disease drug; PBMs come under increased scrutiny

Five things for pharma marketers to know: Thursday, October 19, 2017

Five things for pharma marketers to know: Thursday, October 19, 2017

The FDA approves Kite's CAR-T therapy; Omnicom reports strong Q3 performance for healthcare agencies; Hearst to acquire Rodale, up health presence

Five things for pharma marketers to know: Wednesday, October 18, 2017

Five things for pharma marketers to know: Wednesday, October 18, 2017

More than half of doctors say patients make critical, racist, or sexist comments; Anthem to launch its own PBM; drugmakers face criticism for waste

Novo's experimental diabetes drug likely to compete with Trulicity

Novo's experimental diabetes drug likely to compete with Trulicity

An FDA advisory committee is scheduled to vote Wednesday on whether to approve Novo's semaglutide, which, if approved, could steal market share from Eli Lilly's Trulicity.

Wellpepper wins Alexa Diabetes Challenge

Wellpepper wins Alexa Diabetes Challenge

The health startup's system has a foot scanner that can take photos of a patient's feet and can look for potential foot ulcers using a machine learning image classifier.

Five things for pharma marketers to know: Tuesday, October 17, 2017

Five things for pharma marketers to know: Tuesday, October 17, 2017

J&J reports 15% lift in pharma sales in Q3; Apple reportedly considers buying medical clinics; survey finds need for digital investment in payer marketing

Drugmakers begin to up media controls, in bid to clean up digital ad supply

Drugmakers begin to up media controls, in bid to clean up digital ad supply

Like its consumer-products cousins, pharma marketers are exercising more discipline over online media. Will it yield similar results?

Five things for pharma marketers to know: Monday, October 16, 2017

Five things for pharma marketers to know: Monday, October 16, 2017

FDA briefing document affirms diabetes drug's efficacy; J&J debuts new tools to improve adherence; AZ says cancer drug data was falsified

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.

Five things for pharma marketers to know: Friday, October 13, 2017

Five things for pharma marketers to know: Friday, October 13, 2017

Outcome Health reportedly misled advertisers; FDA committee recommends gene therapy; Avanir drug is highly prescribed by docs paid by company

Muscular Dystrophy Association taps Lynn O'Connor Vos as CEO

Muscular Dystrophy Association taps Lynn O'Connor Vos as CEO

The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.

Five things for pharma marketers to know: Thursday, October 12, 2017

Five things for pharma marketers to know: Thursday, October 12, 2017

Merck scraps plans for cholesterol drug; oncologist describes how he tells people about his work; researchers question list of side effects in DTC ads

Nonprofits focus attention on metastatic breast cancer this October

Nonprofits focus attention on metastatic breast cancer this October

Susan G. Komen and the Breast Cancer Research Foundation are focusing on raising awareness and research money for the deadliest forms of the disease.